Basiran
Taiwan has officially transitioned into a "super-aged society," a demographic milestone where more than 20% of the total population is aged 65 or older. This shift has triggered an urgent call from health experts and policy committees for a fundamental restructuring of the nation’s healthcare framework. While Taiwan’s National Health Insurance (NHI) system is globally recognized for its accessibility, the current infrastructure remains heavily weighted toward "downstream" care—treating diseases after they manifest—rather than "upstream" prevention. As the administration of President Lai Ching-te pushes forward with its "Healthy Taiwan" vision, a new set of comprehensive recommendations has been proposed to strengthen system resilience through precision care, digital innovation, and integrated chronic disease management.
The demographic transition poses a significant threat to the fiscal and operational stability of Taiwan’s healthcare system. Aging populations are inherently more susceptible to chronic diseases, age-related disabilities, infectious threats, and cancer. Without a shift toward early intervention and risk-proactive management, the government warns that long-term costs could become unsustainable, potentially compromising the quality of care for future generations.
Strengthening Chronic Disease Governance Through Precision Care
Chronic diseases, particularly diabetes and chronic kidney disease (CKD), are currently the primary drivers of NHI expenditure. According to data from the National Health Insurance Administration (NHIA), these two conditions alone account for over NT$100 billion in annual costs. To address this, the Committee recommends a transition toward a precision care-oriented model that prioritizes risk stratification.
The current "888 Plan"—a government initiative aimed at achieving an 80% screening rate, 80% treatment rate, and 80% control rate for chronic conditions—serves as the foundation for these reforms. However, experts argue that the model must become more personalized. By identifying high-risk populations—such as those with poor glycemic control, high body mass index (BMI), or early signs of renal impairment—the system can intervene before these conditions escalate into expensive, life-threatening complications.
A critical component of this strategy involves the establishment of a National Chronic Disease Cross-Sector Alliance. This mechanism would coordinate efforts between major medical centers, regional hospitals, and primary care providers. One of the primary hurdles identified is the fragmentation of current Pay-for-Performance (P4P) models. Currently, reimbursement points for early-stage CKD are significantly lower than those for metabolic syndrome or diabetes, which disincentivizes medical institutions from enrolling patients in early intervention programs. By aligning financial incentives with long-term health outcomes rather than the volume of services provided, the government hopes to shorten the average number of "unhealthy years" lived by Taiwanese citizens, which currently stands at eight years.
Furthermore, the Committee suggests that obesity management must be integrated into these precision care strategies. Drawing inspiration from South Korea’s NHI, the proposal includes incorporating BMI into standardized monitoring under the 888 Program and prioritizing overweight populations for longitudinal management, including both lifestyle counseling and pharmacological interventions.
Early Intervention to Prevent Age-Related Disability
As the population ages, the prevalence of functional decline and frailty has become a pressing public health issue. Data from the Health Promotion Administration indicates that approximately 30% of Taiwan’s population aged 65 and above is at risk of disability or frailty. The Committee emphasizes that a policy focused solely on expanding long-term care capacity is insufficient; instead, the focus must shift toward maintaining independent living for as long as possible.
A major pillar of this effort is the advancement of early-stage dementia policies. Historically, Taiwan’s dementia care has focused on moderate to severe stages of the disease. However, with the emergence of new biomarker-based diagnostics—such as blood-based screenings and PET scans—and disease-modifying therapies for Alzheimer’s, there is a significant opportunity to intervene during the "mild cognitive impairment" phase.
The Committee recommends a shift from a disability-focused model to a comprehensive "brain-health management" approach. This includes strengthening the integration between post-acute care and long-term care systems, particularly for stroke and neurodegenerative disease patients. By introducing integrated care models and dedicated case managers, the system can improve rehabilitation adherence and reduce the risk of recurrence, thereby extending the "healthy life expectancy" of the elderly.
Immunization and Infection Prevention as a Pillar of Resilience
Vaccination is widely regarded as one of the most cost-effective public health interventions, yet adult and elderly vaccination coverage in Taiwan remains suboptimal. Influenza vaccination rates among those 65 and older hover around 50%, while pneumococcal vaccination completion rates are below 40%.
To support the "Healthy Taiwan" objectives, the Committee recommends embedding vaccination protocols directly into existing chronic disease management frameworks. For instance, pneumococcal and Covid-19 vaccinations could be used as tracking indicators within the Family Physician Program.
Sustainable financing is also a key concern. While the National Vaccine Fund has seen increased public budget contributions—reaching 76% this year—the remaining 24% still relies on the tobacco surcharge, which may be an unstable long-term source. The Committee advocates for a more transparent pathway for evaluating and including new vaccines, alongside a shift toward risk-based, tiered testing for vaccine lot releases. By adopting documentation-based reviews similar to those in the European Union or A10 countries, Taiwan could improve the efficiency of its vaccine supply chain without compromising safety.
Scaling the Digital Health Ecosystem and Contactless Care
Digital innovation is viewed as the "force multiplier" for Taiwan’s healthcare reforms. The "Health Coin" program, which rewards citizens with digital incentives for participating in preventive health activities, is slated for a significant expansion. The Committee suggests moving beyond simple clinical screenings to include high-frequency preventive behaviors, such as physical activity and weight management, verified through wearable devices.
By integrating data from the "My Health Bank" platform with private-sector wellness partners, the government can create a data-enabled incentive framework. This would allow fitness and nutrition companies to offer rewards based on de-identified health achievements, fostering a public-private ecosystem that promotes wellness without compromising individual privacy.
Additionally, the push for "contactless care" through telehealth is gaining momentum. The goal is to create a seamless care model that integrates teleconsultation, electronic prescriptions, digital payments, and pharmaceutical logistics. This is particularly vital for remote and underserved areas, ensuring that the super-aged population can access high-quality care regardless of their geographical location.
Establishing a Comprehensive Cancer Control Framework
For over four decades, cancer has remained the leading cause of death in Taiwan. Despite significant investments, screening participation remains uneven. While cervical cancer screening has exceeded a 50% participation rate, breast and colorectal cancer screenings remain below 40%. Furthermore, certain cancers, such as prostate and ovarian cancer, are frequently diagnosed at advanced stages, leading to higher mortality rates.
The Committee’s recommendation for cancer control involves a three-pronged approach: expanded screening, improved access to precision diagnostics, and sustainable financing. There is a specific call to optimize reimbursement for Next-Generation Sequencing (NGS) to align with international clinical guidelines, allowing for more tailored and effective treatment plans.
To address the high cost of innovative therapies, the establishment and institutionalization of the Cancer Drugs Fund (CDF) is seen as a priority. The Committee recommends expanding the fund to a NT$10 billion level, ensuring that resource allocation is based on both disease burden and unmet medical needs. Establishing a clear legal framework and a predictable transition for drugs from the CDF to the standard NHI reimbursement system will be essential to ensure continuity of care for patients.
Implications and Future Outlook
The transition to a super-aged society is not merely a demographic shift but a structural challenge that tests the limits of Taiwan’s social contract. The recommendations put forth by the Committee represent a pivot from a reactive healthcare system to a proactive, data-driven, and patient-centric model.
The success of these initiatives will depend heavily on cross-sector coordination. The proposed National Chronic Disease Cross-Sector Alliance and the expansion of public-private partnerships in digital health indicate a move toward a more "networked" governance model. From a fiscal perspective, the focus on "upstream" prevention is an economic necessity. By reducing the number of unhealthy years and delaying the onset of disability, Taiwan can mitigate the projected explosion in long-term care costs.
As the Lai Ching-te administration begins to implement these strategies, the international community will likely look to Taiwan as a laboratory for aging-society solutions. The integration of high-tech digital tools with traditional public health interventions offers a potential blueprint for other developed nations facing similar demographic "graying." However, the path forward requires not just technological innovation, but also significant legislative and cultural shifts in how health is managed across the life course. In the face of an aging population, the "Healthy Taiwan" vision is more than a policy goal—it is a vital strategy for national survival and prosperity.
Dwi Wanna
Asep Darmawan
